Search results
6 dni temu · Get the latest information and complete track record of Tata India Pharma & Healthcare Fund - Direct Plan schemes, returns, latest NAV and ratings from independent mutual fund research house.
2 dni temu · Tata India Pharma & Healthcare Fund Direct-Growth Fund Key Highlights. 1. Current NAV: The Current Net Asset Value of the Tata India Pharma & Healthcare Fund - Direct Plan as of Oct 25, 2024 is Rs 34.75 for Growth option of its Direct plan. 2.
Get the latest Tata India Pharma & Healthcare Fund Direct Growth (TATA_INDI_PHAR_WGSTAL) real-time quote, historical performance, charts, and other financial information to help you...
Primarily focuses on investment in at least 80% of its net assets in equity/equity related instruments of the companies in the Pharma & Healthcare sectors in India.
Lower expense ratio leads to higher returns for investors. Direct. Let's take an example, a mutual fund was priced (NAV) at Rs 100 one year back and fund gave 20% returns in last 1 year. Now for...
Tata India Pharma & Healthcare Fund Direct Growth - Get latest NAV, SIP Returns & Rankings, Ratings, Fund Performance, Portfolio, Expense Ratio, Holding Analysis, and Peers. Invest in Tata India Pharma & Healthcare Fund Online with Groww.
Get detailed Portfolio analysis for Tata India Pharma & Heathcare Fund. Check detailed stocks and debt portfolio holding, changes in portfolio, list of stocks bought/sold, risk analysis of debt ...
